From the Cochrane Library: Topical Tacrolimus for Atopic Dermatitis.
作者信息
Hamp Austin, Anderson Jarett D, Sivesind Torunn E, Szeto Mindy D, Cury-Martins Jade
机构信息
Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ, United States.
Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
出版信息
JMIR Dermatol. 2021 Oct 28;4(2):e31838. doi: 10.2196/31838.
Abstract
摘要
相似文献
1
From the Cochrane Library: Topical Tacrolimus for Atopic Dermatitis.来自考科蓝图书馆：外用他克莫司治疗特应性皮炎。
JMIR Dermatol. 2021 Oct 28;4(2):e31838. doi: 10.2196/31838.
2
Topical tacrolimus for atopic dermatitis.外用他克莫司治疗特应性皮炎。
Cochrane Database Syst Rev. 2015 Jul 1;2015(7):CD009864. doi: 10.1002/14651858.CD009864.pub2.
3
Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.局部用钙调神经磷酸酶抑制剂治疗儿童特应性皮炎的安全性和有效性。
Am J Clin Dermatol. 2005;6(2):65-77. doi: 10.2165/00128071-200506020-00001.
4
Practical algorithm to inform clinical decision-making in the topical treatment of atopic dermatitis.实用算法在特应性皮炎局部治疗中的临床决策中的应用。
J Dermatol. 2021 Aug;48(8):1139-1148. doi: 10.1111/1346-8138.15921. Epub 2021 May 7.
5
A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis.局部皮质类固醇与局部钙调磷酸酶抑制剂治疗特应性皮炎的比较。
J Allergy Clin Immunol Pract. 2023 May;11(5):1347-1359. doi: 10.1016/j.jaip.2023.03.022. Epub 2023 Mar 29.
6
Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.他克莫司和吡美莫司：从聪明的原核生物到抑制钙调神经磷酸酶及治疗特应性皮炎
J Am Acad Dermatol. 2002 Feb;46(2):228-41. doi: 10.1067/mjd.2002.120942.
7
Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use.皮肤科中的外用钙调神经磷酸酶抑制剂。第一部分：药物使用的特性、方法及有效性
Postepy Dermatol Alergol. 2013 Jun;30(3):165-9. doi: 10.5114/pdia.2013.35619. Epub 2013 Jun 20.
8
Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice.他克莫司软膏联合度普利尤单抗治疗特应性皮炎患者的真实世界临床疗效及安全性。
J Dermatol. 2021 Oct;48(10):1564-1568. doi: 10.1111/1346-8138.16039. Epub 2021 Jun 22.
9
Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.局部钙调磷酸酶抑制剂治疗特应性皮炎：安全性问题的最新进展。
J Dtsch Dermatol Ges. 2012 Mar;10(3):167-72. doi: 10.1111/j.1610-0387.2011.07791.x. Epub 2011 Oct 6.
10
A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.韩国一项关于0.03%他克莫司软膏治疗特应性皮炎疗效和安全性的多中心试验。
J Dermatolog Treat. 2004 Jan;15(1):30-4. doi: 10.1080/09546630310020812.
本文引用的文献
1
Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma: A Systematic Review and Meta-analysis.局部钙调磷酸酶抑制剂的使用与癌症（包括淋巴瘤、角化细胞癌和黑色素瘤）风险的关联：系统评价和荟萃分析。
JAMA Dermatol. 2021 May 1;157(5):549-558. doi: 10.1001/jamadermatol.2021.0345.
2
Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis.2%克立硼罗软膏治疗轻至中度特应性皮炎患者：系统文献综述与网状Meta分析
Dermatol Ther (Heidelb). 2020 Aug;10(4):681-694. doi: 10.1007/s13555-020-00389-5. Epub 2020 May 20.
3
No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis.未发现使用外用他克莫司治疗特应性皮炎的儿童癌症发病率增加。
J Am Acad Dermatol. 2020 Aug;83(2):375-381. doi: 10.1016/j.jaad.2020.03.075. Epub 2020 Apr 1.
4
Quality of Life and Disease Impact of Atopic Dermatitis and Psoriasis on Children and Their Families.特应性皮炎和银屑病对儿童及其家庭的生活质量和疾病影响
Children (Basel). 2019 Dec 2;6(12):133. doi: 10.3390/children6120133.
5
Young children with moderate-to-severe atopic dermatitis can be treated safely and effectively with either topical tacrolimus or mild corticosteroids.患有中度至重度特应性皮炎的幼儿使用外用他克莫司或轻度皮质类固醇进行治疗既安全又有效。
Acta Paediatr. 2020 Mar;109(3):550-556. doi: 10.1111/apa.15001. Epub 2019 Oct 7.
6
Topical tacrolimus for atopic dermatitis.外用他克莫司治疗特应性皮炎。
Cochrane Database Syst Rev. 2015 Jul 1;2015(7):CD009864. doi: 10.1002/14651858.CD009864.pub2.
Zotero 插件